Surgery Partners Inc [SGRY] stock is trading at $24.36, down -0.04%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SGRY shares have gain 4.10% over the last week, with a monthly amount drifted -5.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surgery Partners Inc [NASDAQ: SGRY] stock has seen the most recent analyst activity on December 16, 2024, when BofA Securities initiated its Buy rating and assigned the stock a price target of $30. Previously, UBS started tracking the stock with Buy rating on October 14, 2024, and set its price target to $38. On October 11, 2024, KeyBanc Capital Markets initiated with a Sector Weight rating. Macquarie started tracking the stock assigning a Outperform rating and suggested a price target of $31 on June 28, 2024. Barclays initiated its recommendation with a Equal Weight and recommended $35 as its price target on March 06, 2024. TD Cowen upgraded its rating to Outperform for this stock on November 14, 2023, and downed its price target to $35. In a note dated June 02, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $42 to $45.
Surgery Partners Inc [SGRY] stock has fluctuated between $19.50 and $33.97 over the past year. Currently, Wall Street analysts expect the stock to reach $36.33 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $24.36 at the most recent close of the market. An investor can expect a potential return of 49.14% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
Surgery Partners Inc [NASDAQ:SGRY] reported sales of 3.11B for the trailing twelve months, which represents a growth of 17.54%. Gross Profit Margin for this corporation currently stands at 0.23% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.09 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.23 points at the first support level, and at 24.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.48, and for the 2nd resistance point, it is at 24.61.
Ratios To Look Out For
For context, Surgery Partners Inc’s Current Ratio is 1.79. Also, the Quick Ratio is 1.65, while the Cash Ratio stands at 0.43. Considering the valuation of this stock, the price to sales ratio is 1.00, the price to book ratio is 1.73.
Transactions by insiders
Recent insider trading involved Baldock Jennifer, Chief Admin & Dev Officer, that happened on Mar 14 ’25 when 612.0 shares were sold. Chief Human Resources Officer, Burkhalter Danielle completed a deal on Mar 14 ’25 to sell 74.0 shares. Meanwhile, American Group President Webb William Trenton sold 138.0 shares on Mar 14 ’25.
